Longitudinal Access and Adjudication Data (LAAD) brings together IQVIA’s prescription, lifecycle, medical, and remittance claims into a single, de-identified, patient-level transactional dataset, enabling pharmaceutical manufacturers and select digital health companies, academia, medtech, and financial organizations to gain a patient-centric, longitudinal view of healthcare utilization and access.

By consolidating pharmacy, medical, and financial claim events, LAAD supports comprehensive analysis of patient access, utilization, outcomes, market access, financial burden, treatment dynamics, and competitive landscape assessment.

Download the full product description,